Heather Denroche
Co-founder and Director of Preclinical Development Integrated Nanotherapeutics Inc.
Expert in preclinical diabetes research (15 y) from hormones and glucose metabolism to islet inflammation and immune cells. Effective communicator, teacher, mentor, writer and collaborator. Driven to discover and design new ways to help people through science and innovation.
Seminars
Thursday 25th March 2027
Driving Robust Tolerance with Multi-Cargo Lipid Nanoparticles to Advance Safe, Targeted, & Durable Therapeutic Responses
11:30 am
- Explore the updates from our Intergrated Nanotherapeutics T1D preclinical program to understand the therapeutic potential of multi-cargo lipid nanoparticles in antigen- specific immune tolerance
- Demonstrate the translation of antigen selection from preclinical models to the clinic to support more effective and clinically relevant therapeutic design
